These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

43 related items for PubMed ID: 6135658

  • 1. Evidence for an indirect effect of somatostatin on glucagon secretion via inhibition of free fatty acids release in the duck.
    Strosser MT, Foltzer C, Cohen L, Mialhe P.
    Horm Metab Res; 1983 Jun; 15(6):279-83. PubMed ID: 6135658
    [No Abstract] [Full Text] [Related]

  • 2. Pituitary and adrenal control of pancreatic endocrine function in the duck. III. Effects of glucose, oleic acid, arginine, insulin and glucagon infusions in hypophysectomized or normal ducks.
    Foltzer C, Mialhe P.
    Diabete Metab; 1980 Dec; 6(4):257-63. PubMed ID: 7009247
    [Abstract] [Full Text] [Related]

  • 3. Pituitary and adrenal control of pancreatic endocrine function in the duck. II. Plasma free fatty acids, aminoacids, and insulin variations following hypophysectomy and replacement therapy with growth hormone and corticosterone.
    Foltzer C, Mialhe P.
    Diabete Metab; 1976 Sep; 2(3):101-5. PubMed ID: 1010117
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S, Escobar-Jimenez F, Rosenthal J, Ditschuneit HH, Pfeiffer EF.
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [Abstract] [Full Text] [Related]

  • 5. Free fatty acids and pancreatic function in the duck.
    Gross R, Mialhe P.
    Acta Endocrinol (Copenh); 1986 May; 112(1):100-4. PubMed ID: 2872764
    [Abstract] [Full Text] [Related]

  • 6. Control of plasma levels of growth hormone, glucagon and insulin in ducklings: roles of free fatty acids and somatostatin.
    Foltzer C, Strosser MT, Harvey S, Mialhe P.
    J Endocrinol; 1985 Jul; 106(1):21-5. PubMed ID: 2862214
    [Abstract] [Full Text] [Related]

  • 7. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 8. The effect of somatostatin on epinephrine-induced free fatty acid release in normal man.
    Botha JL, Vinik AI, Child P, Lund A, van Tonder S.
    S Afr Med J; 1977 Dec 10; 52(25):995-7. PubMed ID: 607511
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J.
    Horm Metab Res; 1981 Jul 10; 13(7):371-5. PubMed ID: 6792023
    [Abstract] [Full Text] [Related]

  • 10. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr 10; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin stimulates glucagon secretion in ducks.
    Strosser MT, Cohen L, Harvey S, Mialhe P.
    Diabetologia; 1980 Apr 10; 18(4):319-22. PubMed ID: 6106614
    [Abstract] [Full Text] [Related]

  • 12. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J, Efendić S, Luft R, Hagenfeldt L, Björkman O, Felig P.
    J Clin Invest; 1977 Feb 10; 59(2):299-307. PubMed ID: 833277
    [Abstract] [Full Text] [Related]

  • 13. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE, Langlois M, Schneider V, Karam JH, Noacco C.
    J Clin Invest; 1974 May 10; 53(5):1284-9. PubMed ID: 4825225
    [Abstract] [Full Text] [Related]

  • 14. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS, Ho LT.
    Horm Metab Res; 1987 Jun 10; 19(6):253-6. PubMed ID: 2887501
    [Abstract] [Full Text] [Related]

  • 15. Pituitary and extrapituitary effects of somatostatin in normal man.
    Copinschi G, Leclercq-Meyer V, Virasoro E, L'Hermite M, Vanhaelst L, Golstein J, Leclercq R, Féry F, Robyn C.
    Horm Metab Res; 1976 May 10; 8(3):226-31. PubMed ID: 181309
    [Abstract] [Full Text] [Related]

  • 16. Roles of insulin and glucose in the regulation of plasma FFA in the duck. I. In the absence of pancreatic glucagon.
    Gross R, Mialhe P.
    Diabetologia; 1978 Mar 10; 14(3):185-90. PubMed ID: 658635
    [Abstract] [Full Text] [Related]

  • 17. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL, Compagnie MJ, Dellenbach P, Stephan F.
    Nouv Presse Med; 1980 Sep 13; 9(32):2247-51. PubMed ID: 6106923
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE, Langlois M, Noacco C, Lorenzi M, Karam JH, Korsham PH.
    J Clin Invest; 1976 Aug 13; 58(2):320-5. PubMed ID: 783198
    [Abstract] [Full Text] [Related]

  • 19. Effect of free fatty acids and amino acids on glucagon and insulin secretions in normal and diabetic ducks.
    Laurent F, Mialhe P.
    Diabetologia; 1978 Oct 13; 15(4):313-21. PubMed ID: 710754
    [Abstract] [Full Text] [Related]

  • 20. Physiologic effects of epinephrine on glucose turnover and plasma free fatty acid concentrations mediated independently of glucagon.
    Gray DE, Lickley HL, Vranic M.
    Diabetes; 1980 Aug 13; 29(8):600-8. PubMed ID: 6108271
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.